Clinical trial
A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
NCT01647906 is registered in ClinicalTrials.gov with Bausch Health Americas, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Single Arm, Multicenter, Observational Assessment of the Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI)
- Lead sponsor
- Bausch Health Americas, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2012
- Completion date
- September 15, 2018
- Enrollment
- 277 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.